Skip to main content
. 2013 Apr 8;2:10. doi: 10.1186/2162-3619-2-10

Table 1.

Clinical and immunophenotypic features of T-ALL patients at diagnosis according to expression of miR-221 and miR-374

Patient characteristics
miR-221
 
miR-374
 
  High expression Low expression P-value High expression Low expression P-value
Age1, years
22.8 (1 – 66)
17.4 (2 – 44)
0.22
23.6 (1 – 66)
16.8 (2 – 44)
0.49
Gender (M/F)
24(18/6)
24 (21/3)
0.46
24(21/3)
23(17/6)
0.12
Mediastinal mass (%)
14/24(58)
6/24 (25)
0.15
15/24 (62.5)
5/23(22)
0.13
Lymphadenopathy (%)
15/24(62.5)
21/24 (87.5)
0.26
16/24 (67)
19/23(83)
0.24
Splenomegaly (%)
16/24(67)
16/24 (67)
0.66
17/24 (71)
14/23(61)
0.6
Hepatomegaly (%)
15/24(62.5)
16/24 (67)
0.99
17/24 (71)
13/23(56.5)
0.44
CNS involvement (%)
1/24(4)
2/24 (8)
0.56
2/24 (8)
1/23(4)
0.53
Blasts BM1 (%)
77.3 (20 – 100)
90.5 (28 – 100)
0.09
77.6 (20 – 100)
90.7 (28 – 100)
0.64
Blasts PB1 (%)
63.4 (0 – 100)
78.5 (10 – 100)
0.18
61.5 (0 – 100)
86 (10 – 100)
0.45
Hemoglobin1 (g/l)
10.4 (3.6 – 15.6)
10.4 (4.6 – 17.1)
0.97
10.1 (3.6 – 15.8)
10.8 (5.3 – 17.1)
0.4
WBC1 count × 109/l
104 (4.6 – 314)
202.3 (4.5 – 790)
0.06
118 (4.5 – 781)
196 (18 – 789)
0.61
Platelets1 × 109/l
149.4 (9 – 652)
48.8 (9 – 185)
0.009*
140 (9 – 652)
55.8 (9 – 231)
0.03*
Pre thymic (%)
7/24(29)
4/24(17)
0.31
6/24 (25)
5/23(22)
0.81
Thymic (%)
7/24(29)
10/24(42)
0.54
9/24 (37.5)
7/23(30)
0.51
Mature T (%)
8/24(33)
8/24(33)
0.98
7/24 (29)
9/23(39)
0.37
CD34 (%)
16/24(67)
8/24(33)
0.042*
13/24 (54)
11/23(48)
0.56
CD56 (%)
11/24(46)
1/24(4)
0.001*
12/24 (50)
1/23(4)
<0.001*
TdT (%) 18/24(75) 21/24(87) 0.46 17/24 (71) 21/23(91) 0.28

CNS: central nervous system; WBC: white blood cell; PB: peripheral blood; BM: bone marrow; cCD3: cytoplasmic CD3; sCD3: surface CD3; TdT: terminal deoxynucleotidyl transferase. *Significant P-value.

1 Values represent mean (range).